【1ヶ月でガチ痩せ】◯◯するだけで楽痩せするルーティンを医師が徹底解説

👉️Manjaro's online consultations are available via [Official LINE] https://lstep.app/zXFPzsp ◆━━━━━━━━━━━━━━━━━━◆ \ Achieve your last diet ever! 🔥 / ✅ Say goodbye to strict exercise and diet restrictions! ✅ Over 10,000 successful cases! Knowledge and clinical experience based on medical evidence ✅ Thorough follow-up after prescription \ For consultations and online consultations, please use our official LINE 💁‍♂️ / Dr. Kenshin will respond directly! https://lstep.app/zXFPzsp \ Want to work with Dr. Kenshin? Click here! 💁 / https://forms.gle/3RzYoe6k2ur1GXFf7 ▼Video Table of Contents▼ 00:00 About this video 01:19 How to lose 5kg in one month? 03:14 Drink water 04:28 Control your diet 08:55 Get quality sleep 09:52 Exercise 11:16 Reduce alcohol consumption 13:54 To lose 5kg, use XX! ▼Watch the video on how to absolutely prevent rebound weight gain here▼    • 【ダイエット】もう二度と太らない！リバウンドしにくい食べ物を医師が解説します。   ▼Watch the video explaining constipation relief medication here▼    • 【お腹が凹む！】 ダイエット中の便秘を一気に解消！痩せたい人は必ず見てください。   ▼Watch the video behind the scenes of medical dieting here▼    • 薬でダイエットするのって本当に危険なの？医師がメディアの偏向報道に物申す   ●Official LINE https://lstep.app/zXFPzsp ●Instagram   / tsukuba_ken_clinic   ●TikTok   / diet_dr.kenshin   ●Homepage https://tsukuken.clinic ────────────────── 【About Treatment Details】(Disclosure of Important Information) 1. Regarding Medical Treatment and Prescriptions at Our Clinic At our clinic, we may prescribe type 2 diabetes medications (GLP-1 receptor agonists, SGLT2 inhibitors, metformin, etc.) as a private medical service (for obesity treatment) at the discretion of the physician. Since these medications are not approved for obesity treatment in Japan, this constitutes off-label use. We will make a comprehensive judgment based on examination, test results, and medical history, and we cannot prescribe them to all patients. 2. Main Purpose and Indications of Treatment All of these medications are approved for the purpose of blood glucose control in type 2 diabetes. Use for obesity treatment will be carried out only after thorough explanation and informed consent, taking into account domestic and international approval status and academic society guidelines. 3. Individual Differences in Efficacy, Side Effects, and Risks Taking these medications or injecting them does not necessarily guarantee a certain level of weight loss. There are significant individual differences in effectiveness, and it is essential to use them in conjunction with lifestyle changes, dietary therapy, and exercise therapy. Side effects such as hypoglycemia and gastrointestinal symptoms may occur; please consult a doctor immediately if you experience any discomfort. 4. Possibility of Examinations and Additional Treatment Continuing treatment may require regular examinations (blood tests, urine tests, etc.). Consultation fees, examination fees, and additional medication costs may be incurred separately. 5. Precautions Regarding Private Medical Treatment Prescriptions for obesity treatment are not covered by health insurance (full self-payment). Because it is off-label use, it may not be covered by the national drug side effect relief system. 6. Comparison with Other Treatment Methods and Guarantees This treatment is merely one option and does not guarantee superiority over other medical institutions or other treatment methods. Treatment effectiveness and the risk of side effects vary from person to person, and the expected results are not always guaranteed. ────────────────── ●GLP-1 Receptor Agonist (Oral Medication: Rybelsus) 【Treatment Details】 Rybelsus is an oral GLP-1 receptor agonist, used for blood glucose control in type 2 diabetes. At our clinic, it may be prescribed for obesity treatment at the doctor's discretion (off-label use). Weight loss is expected due to its appetite-suppressing effect and sustained feeling of fullness. [Dosage and Administration] Take once daily before breakfast with 120 mL or less of water. Avoid eating or drinking for 30 minutes after taking the medication (to maximize its effectiveness). The initial dose is 3 mg, increasing to 7 mg after one month, and can be increased up to 14 mg as needed. [Standard Cost] Rybelsus 3 mg (30-day supply): ¥8,480 7 mg (30-day supply): ¥18,480 14 mg (30-day supply): ¥26,980 [Main Risks and Side Effects] Gastrointestinal symptoms (nausea, vomiting, diarrhea, constipation), loss of appetite, acute pancreatitis (extremely rare) [Regarding the Use of Unapproved Drugs] Rybelsus is approved by the Ministry of Health, Labour and Welfare as a treatment for type 2 diabetes, but its prescription for the treatment of obesity is not approved in Japan. [Regarding the Source of Acquisition] This drug is purchased from a domestic authorized distributor (pharmaceutical wholesaler). [Availability of Domestically Approved Drugs] Ugobi, containing the same active ingredient as Rybelsus, and Sanorex are approved in Japan as treatments for obesity. [Information on S...